abnormal B cell activation_Blnk<tm1Kplm>/Blnk<tm1Kplm>

http://metadb.riken.jp/0008217I129P2OlaHsdBlnktm1KplmBlnktm1KplmBlnktm1Kplm

abnormal B cell activation_Blnk<tm1Kplm>/Blnk<tm1Kplm>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• B cell linker
  http://metadb.riken.jp/db/mgi_rdf/MGI:96878

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Blnk<tm1Kplm>/Blnk<tm1Kplm>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Blnk<tm1Kplm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal B cell activation
  http://purl.obolibrary.org/obo/MP_0008217

文献

http://purl.org/net/cito/citesAsAuthority

• Shengli. Xu, et.al., Phospholipase Cgamma2 dosage is critical for B cell development in the absence of adaptor protein BLNK., Journal of immunology (Baltimore, Md. : 1950), 2006, 176
  http://rdf.ncbi.nlm.nih.gov/pubmed/16585562
• S. Xu, et.al., B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice., International immunology, 2000, 12
  http://rdf.ncbi.nlm.nih.gov/pubmed/10700474